Get the Daily Brief
Latest Biotech News
Supernus Acquires Sage Therapeutics for Up to $795 Million
Supernus Pharmaceuticals is acquiring Sage Therapeutics, a central nervous system-focused biotech, for approximately $561 million upfront with potential milestone payments elevating the deal value...
Innovations in AI and Machine Learning for Biotech Applications
Artificial intelligence continues to drive transformative advances in biotech. At the BIO 2025 AI Summit, industry leaders highlighted both rapid growth and the nascent, evolving nature of AI in...
New Imaging and Diagnostic Technologies Address Medical Challenges
Recent technology breakthroughs promise enhanced diagnostic power and patient care. Researchers at King’s College London developed a nanoneedle patch with tens of millions of microscopic needles...
New Therapeutic Strategies and Drug Development Updates
Recent advancements in drug discovery and development highlight innovative therapeutic strategies. Swedish researchers introduced a dual antioxidant enzyme inhibition approach to induce...
Advances in CRISPR and Gene Editing Technologies
Innovative developments in gene editing continue to expand therapeutic possibilities. The University of California and University of Vienna secured a court ruling to reconsider the CRISPR–Cas9...
Environmental and Ecological Research Insights
Emerging environmental research highlights critical ecosystem and climate dynamics. A team from the Catholic University of the Sacred Heart identified soil bacteria in Italy’s Veneto region...
Breakthroughs in Biomedical Imaging and Computational Tools
Novel computational and imaging tools are enhancing biomedical research precision. Virginia Commonwealth University launched TACIT, a machine learning algorithm that accelerates cell type...
New Materials and Robotics for Medical and Technology Applications
Researchers are pioneering materials and robotic systems to advance medical and industrial technologies. MIT engineers developed a compact, low-power receiver chip extremely resistant to...
Supernus Acquires Sage Therapeutics for Up to $795 Million
Supernus Pharmaceuticals has agreed to acquire Sage Therapeutics for approximately $561 million upfront, with additional contingent payments potentially raising the total to $795 million. The...
FDA Faces Resource Strains Leading to Review Delays
The FDA is experiencing ongoing resource constraints impacting its ability to meet drug approval deadlines. Commissioner Marty Makary has proposed consolidations of administrative functions to...
Sarepta Halts Duchenne Gene Therapy Shipments After Second Patient Death
Sarepta Therapeutics has suspended shipments of its Duchenne muscular dystrophy gene therapy Elevidys for non-ambulatory patients following a second death due to acute liver failure. Both...
Advances in AI-Driven Medical Imaging and Diagnostics
Innovations in artificial intelligence are transforming medical diagnostics with breakthroughs in tumor segmentation and imaging genomics. Researchers in Tokyo developed MHP-Net, an AI model that...
NextCure Advances ADC Program with $745 Million Simcere Deal
NextCure has secured ex-China rights to Simcere Zaiming’s early-stage ADC candidate SIM0505 targeting CDH6 for up to $745 million. The antibody-drug conjugate combines a CDH6-targeted antibody...
CRISPR Patent Dispute Revived by US Appeals Court
A US appeals court has revived the patent dispute over CRISPR–Cas9 gene-editing technology between the University of California/University of Vienna team and the Broad Institute. The court found...
Nanoneedle Patch Enables Painless, Repeatable Tissue Diagnostics
Scientists at King’s College London have created a nanoneedle patch comprising millions of microscopic needles that collect molecular information from living tissues without pain or damage. This...
Breakthroughs in Cancer and Genetic Mutation Detection Tools
New computational algorithms are enhancing the detection of hidden protein variants resulting from complex genetic changes. UCLA and University of Toronto researchers developed moPepGen, a...
Roche and Prothena Proceed with Phase 3 Parkinson’s Trial Despite Mixed Results
Roche and Prothena are advancing prasinezumab, a Parkinson's disease antibody, into Phase 3 trials despite previous mid-stage studies missing primary endpoints. Analysts at Jefferies estimate only...
AI Applications Track Wildlife Behavior and Urban Ecological Impacts
Researchers at EPFL have launched MammAlps, a multi-view, multi-modal dataset capturing detailed wildlife behavior in the Swiss Alps, enabling sophisticated AI analysis to enhance conservation...
BioMérieux Bolsters Infectious Disease Diagnostics With Day Zero Acquisition
BioMérieux has expanded its next-generation sequencing (NGS) infectious disease testing capabilities through the acquisition of Day Zero Diagnostics' assets for approximately $25 million. Day...
Sage Therapeutics Acquired by Supernus for Up to $795 Million After Biogen Bid Rejection
Supernus Pharmaceuticals has agreed to acquire Sage Therapeutics for up to $795 million, including cash payments and contingent value rights tied to commercialization milestones. This acquisition...